Concepedia

PREVENTION OF VISION LOSS AFTER CATARACT SURGERY IN DIABETIC MACULAR EDEMA WITH INTRAVITREAL BEVACIZUMAB

Aitor Lanzagorta-Aresti, Elena Palacios-Pozo, José Luis Menezo Rozalen, Amparo Návea

Retina · 2009 · 70 citations · 23 references

DOI

Abstract

Intravitreal bevacizumab immediately after phacoemulsification prevents exacerbation of the macular edema seen in many diabetic patients undergoing cataract surgery. In addition, this effect seems to hold in the short term.

References

23

Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders

Lloyd Paul Aiello, Robert L. Avery, Paul G. Arrigg et al. · New England Journal of Medicine · 1994 · 3.8K citations · Full text

A Phase II Randomized Double-Masked Trial of Pegaptanib, an Anti–Vascular Endothelial Growth Factor Aptamer, for Diabetic Macular Edema

Emmett T. Cunningham, Anthony P. Adamis, Michael M. Altaweel et al. · Ophthalmology · 2005 · 590 citations

, , +6

VEGF-initiated blood-retinal barrier breakdown in early diabetes.

Tamim Qaum, Qingguo Xu, Antonia M. Joussen et al. · PubMed · 2001 · 508 citations

Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion.

Philip J. Rosenfeld, Anne E. Fung, Carmen A. Puliafito · PubMed · 2005 · 467 citations

, , +9

Optical Coherence Tomography Findings After an Intravitreal Injection of Bevacizumab (Avastin®) for Macular Edema From Central Retinal Vein Occlusion

Philip J. Rosenfeld, Anne E. Fung, Carmen A. Puliafito · Ophthalmic surgery, lasers & imaging retina · 2005 · 339 citations

, , +11